ABOUT US BOARD OF DIRECTORS

Mrs.Kleiman serves as the CFO of a large diamond company, and as an internal auditor of a local municipality.

Ms. Alon joined Pitango in 1998. With over 26 years of international experience in the high-tech medical industry, Ms. Ruth Alon heads the life sciences activities at Pitango. Ms. Alon previously worked on Wall Street where she held senior positions with Montgomery Securities and Kidder Peabody & Co. As a senior medical device analyst, Ms. Alon was rated as one of the top in her field for four consecutive years. She also managed her own independent consulting business in San Francisco, providing broad-based services to early-stage companies and venture capitalists in the medical devices industry. Ms. Alon has a B.A. in Economics from the Hebrew University of Jerusalem, an M.B.A. from Boston University, and an M.S. from the Columbia University School of Physicians and Surgeons.

Mr. Bianco has over 20 years of executive management experience. Before joining HealOr, Mr. Bianco served as CEO of Agis Industries where he has transformed Agis Ltd. from a local enterprise with a turnover of $15 million into a multimillion dollar internationally known pharmaceutical company. In 1992, Mr. Bianco lead the IPO of Agis on the Tel-Aviv Stock Exchange and in 1994 he played an active part in the acquisition of Clay-Park Labs Inc. by Agis and was appointed to Clay-Park's Board of Directors. He is currently director at the Tel-Aviv Stock Exchange, Topspin Medical, Biocancell and is involved in several other biotech companies.

Mr. Inbar has over 23 years of experience in the banking industry, most of it with the Leumi Group, in Israel and abroad. Since 1988 Mr. Inbar held several executive positions such as EVP and Head of the branches division of Union Bank, CEO of Leumi Canada and CEO of Leumi & Co the investment banking arm of Leumi Group. Mr. Inbar is the managing partner of Shifmen Inbar, a boutique investment advisory shop, and active as a board member of public and privet companies. Mr. Inbar holds a BA degree in Social Science and MA degree in Law, both from Bar-Ilan University, Ramat Gan, Israel.

Dr. Tennenbaum is an acknowledged specialist in skin physiology and pathology, gene therapy and PKC signaling. She is the laureate of prestigious awards and grants including the Rothschild fellowship award, Fulbright award, ISF, GIF, ICRF and DKFZ grants and the J&J focus-funding program. Dr. Tennenbaum is the author of over 50 articles in peer review journals in skin research. Dr. Tennenbaum holds an MD and a Ph.D in pharmacology and cell biology from the Hebrew University Hadassah Medical School, Jerusalem, Israel.

Mr. Shaviv is a leading expert in management of pharmaceutical a chemical industry. Before joining HealOr, Mr. Shaviv served as CEO of ChemAgis and VP of Agis Industries. Prior to that Mr. Shaviv held several management positions in Teva R&D. Mr. Shaviv has extensive international experience in business development in the US, Europe and the Far East. Currently Mr. Shaviv serves as director of several companies in the biotech field. Mr. Shaviv consults HealOr on CMC and regulatory development and business development.